Invention Grant
- Patent Title: HIV-1 GP41 neutralization domain and use thereof
- Patent Title (中): HIV-1 GP41中和结构域及其用途
-
Application No.: US12672585Application Date: 2008-08-11
-
Publication No.: US08475799B2Publication Date: 2013-07-02
- Inventor: Abraham Pinter
- Applicant: Abraham Pinter
- Applicant Address: US NJ New Brunswick
- Assignee: University of Medicine and Dentistry of New Jersey
- Current Assignee: University of Medicine and Dentistry of New Jersey
- Current Assignee Address: US NJ New Brunswick
- Agency: Licata & Tyrrell P.C.
- International Application: PCT/US2008/072764 WO 20080811
- International Announcement: WO2009/021230 WO 20090212
- Main IPC: A61K39/42
- IPC: A61K39/42 ; A61K39/21 ; C07K16/00
Abstract:
The invention relates to isolated monoclonal antibodies which specifically bind to the C-terminal heptad repeat region of gp41 (HR2) and neutralize an HIV-1 primary isolate.
Public/Granted literature
- US20110091491A1 HIV-1 GP41 NEUTRALIZATION DOMAIN AND USE THEREOF Public/Granted day:2011-04-21
Information query
